Zobrazeno 1 - 10
of 50
pro vyhledávání: '"LI-SONG TENG"'
Autor:
Guang-hao Wu, Chao He, Gang Che, Zheng Zhou, Bi-ying Chen, Hai-ming Wu, Jian-feng Chen, Wei-pu Zhu, Yan Yang, Zhan Zhou, Li-song Teng, Hai-yong Wang
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30505- (2024)
FERMT2 has been identified as a participant in integrin-linked kinase signaling pathways, influencing epithelial-mesenchymal transition and thereby affecting tumor initiation, progression, and invasion. While the character of FERMT2 in the tumor micr
Externí odkaz:
https://doaj.org/article/cb7ef034adc745a9b0af4e7e0a428a01
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Long noncoding RNAs (lncRNAs) play a significant role in cancer biology. This study aimed to determine the roles of lncRNAs in establishing the differences in clinical features between patients with papillary thyroid carcinoma (PTC) without Hashimoto
Externí odkaz:
https://doaj.org/article/9755a4b919ad4da684850cf286746817
Autor:
Dan-Fang Yan, Wen-Bao Zhang, Shan-Bao Ke, Feng Zhao, Sen-Xiang Yan, Qi-Dong Wang, Li-Song Teng
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Diffusion-weighted MR imaging (DWI) has increasingly contributed to the management of nasopharyngeal carcinoma (NPC) patients. The objective of this paper was to explore the prognostic significance of apparent diffusion coefficien
Externí odkaz:
https://doaj.org/article/c19edec8b89c4c348648f8f954617d30
Publikováno v:
World Journal of Clinical Cases. 10:9104-9111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac231fbebfe814508c926cc5928d5d5e
https://doi.org/10.12998/wjcc.v10.i25.9104
https://doi.org/10.12998/wjcc.v10.i25.9104
Background Large B-cell lymphoma (LBCL) with interferon regulatory factor 4 (IRF4) rearrangement (LBCL-IRF4) is a rare entity of LBCL with a specific clinical presentation. Notably, it is defined by the presence of an IRF4 rearrangement. Case present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6cba5cc8ebb765a64065f8fc670bcb3
https://doi.org/10.21203/rs.3.rs-1860645/v1
https://doi.org/10.21203/rs.3.rs-1860645/v1
Publikováno v:
Investigational New Drugs. 38:1334-1341
Background Pembrolizumab has robust antitumor activity in advanced melanoma and has been approved for the treatment of melanoma in many countries. Adjuvant pembrolizumab was associated with longer recurrence-free survival (RFS) in patients with resec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::234ee9bd44e0432f3f38e8a3aac3bc74
https://doi.org/10.1007/s10637-020-00913-6
https://doi.org/10.1007/s10637-020-00913-6
Publikováno v:
Frontiers in oncology. 12
Long noncoding RNAs (lncRNAs) play a significant role in cancer biology. This study aimed to determine the roles of lncRNAs in establishing the differences in clinical features between patients with papillary thyroid carcinoma (PTC) without Hashimoto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd6f9b15a4c427496685b5e3d52803e
https://pubmed.ncbi.nlm.nih.gov/35359359
https://pubmed.ncbi.nlm.nih.gov/35359359
Autor:
Zhong Bing Ma, De Zong Gao, Jian Guo Zhang, Hong Chuan Jiang, Yu Juan Xiang, Liang Li, Li Yuan Liu, Chao Zheng, Feng Jin, Zhi Min Fan, Shu Wang, Xiang Wang, Fei Wang, Shu Ya Huang, Li Li Tang, Fernandez-Escobar Alejandro, Fei Zhou, Li Xiang Yu, Qiang Zhang, Li Song Teng, Hong Ying Jia, Cui Zhi Geng, Qin Ye Fu, Zhigang Yu, Qi Wang
Publikováno v:
The Journal of International Medical Research
Journal of International Medical Research, Vol 48 (2020)
Journal of International Medical Research, Vol 48 (2020)
Objective To identify atypical hyperplasia (AH) of the breast by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS), and to explore the molecular fingerprinting characteristics of breast AH. Methods Breast hyperplasia was studied in 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e93052af2cd86a693a2e88f0271d386
https://pubmed.ncbi.nlm.nih.gov/32589079
https://pubmed.ncbi.nlm.nih.gov/32589079
Publikováno v:
Annals of Oncology. 31:S1363-S1364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ff5af8970dfa6a399c9cc0f6bf7997d
https://doi.org/10.1016/j.annonc.2020.10.306
https://doi.org/10.1016/j.annonc.2020.10.306
Publikováno v:
Investigational new drugs. 38(5)
Background Pembrolizumab has robust antitumor activity in advanced melanoma and has been approved for the treatment of melanoma in many countries. Adjuvant pembrolizumab was associated with longer recurrence-free survival (RFS) in patients with resec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::771ae860220cb94121e78e9c91df3833
https://pubmed.ncbi.nlm.nih.gov/32072356
https://pubmed.ncbi.nlm.nih.gov/32072356